Dr. Steve Burton has over 32 years of experience in company management, business development and the development of separation products and processes for the purification of biopharmaceuticals. He has been instrumental in the development of Prometic’s purification products and technologies which are used extensively for commercial manufacture of recombinant and plasma-derived protein therapeutics. Under Dr Burton’s direction, Astrea Bioseparations has grown to become a leading company in its field with a reputation for innovative, high quality/high performance chromatography adsorbents.
Dr. Burton gained his Ph.D. at the University of Cambridge and worked for Delta Biotechnology (now Albumedix) in the UK before joining Astrea Bioseparations in 1988 as Research and Development Manager. Dr Burton has held various positions within Astrea Bioseparations and is currently President of Astrea UK & Isle of Man based bioseparations subsidiary.
Andy is an Experienced Sales Director with over 25 years’ experience in the biotech and life sciences sectors, specialising in bioprocessing and bioseparation techniques with degree level Biochemistry from the University of West London. Having started his career working in a research and development laboratory, Andy progressed into consultative sales roles for capital high-tech equipment and strategic account management, leveraging his lab experience for large pharmaceutical companies such as GE.
Andy has been with Astrea Bioseparations (Astrea) for over 5 years with responsibilities covering the global sales and marketing of its products and services. Since joining Astrea, Andy has been instrumental in developing the product pipeline by successfully launching the ever-growing Evolve column range into Astrea’s offering
Patrick Gurgel has a BSc in Food Engineering (UFV, Brazil), an MSc in Food Science and Technology (UFV) and a PhD in Food Science (NCSU, USA). He joined Prometic in 2003 as a Senior Research Scientist, working on the prion removal project (PRDT) at NCSU, and subsequently becoming the Technical Manager of PRDT.
In 2016 Patrick started his tenure as Senior Director, R&D of Astrea Bioseparations, in Cambridge, UK, where he leads a team of researchers developing chromatographic adsorbents and resins used in biomanufacturing. Before joining Astrea, Patrick was a Senior Researcher at CDB, a bioprocessing research centre in his native Brazil, where he was responsible for the downstream processing group.
Phil is an experienced Technical Manager who has worked in biotech / pharmaceutical manufacturing for over 25 years. After attaining a Ph.D in Chemical Engineering from Lehigh University, Phil started his career as a process engineer in API manufacturing. He has progressed to various leadership roles in manufacturing, quality and technical support in large and small organisations.
Phil has worked at Astrea Bioseparations since 2015 where he set up the Technology Transfer team. In his role as Technology Transfer Manager, Phil is responsible for the smooth introduction of new products to the Isle of Man manufacturing, including process and analytical method validation.
Dev Baines is the Technical Director at Astrea Bioseparations Ltd. based in Cambridge, UK. He joined PBL team in 1996 and has held several positions within the Cambridge Research & Development focusing on development and manufacture of specific custom chromatography adsorbent manufacture and providing solutions for downstream processing of biopharmaceuticals. He has over 35 years of experience in the pharmaceutical sector, in research and pre-clinical development of biopharmaceuticals derived from recombinant expression and natural sources (human plasma).
Colin has over 20 years management experience in Quality and Regulatory Affairs within the Pharmaceutical and Biotech sector. Having begun his career within Quality Control in GSK he moved into other areas of compliance including Herbal, Small Molecule, ATMP and Human Tissue implementing and maintaining HTA and GMP licences in a number of sites using a ISO 9001 Quality Management System and associated certifications.
Colin joined Astrea Bioseparations in 2015 to implement and develop a Quality Management System that adheres to GMP for Active Substances, is compliant with ISO 9001:2015 and uses a Lean approach to manufacturing.
David is an experienced Chief Financial Officer who has worked in the Astrea Group in various roles since 2007. David joined the Company as UK Financial Controller after obtaining a Bachelor’s degree in Business Studies from the University of Nottingham and then going on to qualify with the Institute of Chartered Accountants in England and Wales within practice, gaining vital commercial and technical experience within multiple sectors. He then progressed to be Group Director of Financial Planning & Analysis, and Finance Director before moving into his current role in early 2020 as Chief Financial Officer.
David heads up the finance team in the UK, whilst working closely with the CEO and other management team members to provide a wealth of commercial and strategic insight and direction.
Liz is an experienced Financial Controller with nearly 20 years’ experience of working in Finance, 15 of which in the Pharmaceutical and Bio-Technology industry. She is a qualified member (and fellow) of the Association of Chartered Certified Accountants, since 2011, and the Association of Accounting Technicians, since 2007.
Liz joined the Finance Team at Astrea Bioseparations Ltd (Astrea) in 2009. Since joining Astrea she worked her way up to her current role of Financial Controller in 2014, where she now manages an expanding team. Reporting to the Cheif Financial Officer, Liz’s responsibilities range from the day-to-day running of the financial activities of Astrea, to providing commercial support to the management team and wider business.
Chris is an Experienced production manager with over 27 years’ experience in chemical and pharmaceutical manufacturing. Having started his career working in a research and development laboratory, Chris progressed into large scale manufacturing of fine chemicals and then into Pharmaceutical API manufacturing with Pfizer. He has a degree in Applied chemistry and is a Chartered Manager.
Chris has been with Astrea Bioseparations (Astrea) for over 6 years with responsibilities covering the manufacturing of mimetic adsorbents. Since joining Astrea, Chris has been instrumental in developing a 5-fold increase in manufacturing capacity to meet Astrea’s ambitious growth expectations.
Being an accredited Member of the Chartered Institute of Procurement and Supply (MCIPS), Tim brings with him more than thirty years of experience, including thirteen in the pharmaceutical and biotechnology industry.
As Procurement Manager, Tim is responsible for the supply chain management, establishing and building relationships with suppliers, managing their performance and monitoring costs.
Debbie began her HR career working for the NHS, since this she has progressed to various HR leadership roles in technology, science and manufacturing – with over 25 years’ experience in these sectors. Debbie is a Fellow of the Chartered Institute of Personnel & Development and has a total of 40 years’ experience in HR.
Debbie started at Astrea Bioseparations in 2019 as Head of Human Resources before moving on to her current role of HR Director.
Warren is responsible for all legal aspects of the Astrea group’s business. Warren qualified as a lawyer with top 10 global law firm Dentons, and subsequently gained 20 years of experience at various high growth IP driven businesses in both the UK and US before joining Astrea in early 2020. Warren is a dual qualified UK solicitor and US attorney. With an MBA from UCLA Anderson, Warren also draws from various past non-legal experience in sales, business development and as an entrepreneur to always provide pragmatic and commercial legal advice to the executive team of Astrea.